STALNECKER SUSAN M — SEC Form 4 filings
SEC reporting owner CIK 1221375. 7 Form 4 filings on record with FilingPulse; latest filed 2026-06-04.
Transaction summary — filings shown
Covers all 7 filings on record, filed 2024-05-03 to 2026-06-04. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 1 leg across 1 filing — 3,014 shares, $427,909 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 25.
- Largest priced transaction: sale of 3,014 shares @ $141.97 ($427,909) in Leidos Holdings, Inc., filed 2024-05-03.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Leidos Holdings, Inc. (LDOS) | Director | 3 | — | 1 leg · 3,014 sh · $427,909 | 16 |
| Bioventus Inc. (BVS) | Director | 4 | — | — | 9 |
Form 4 filings — STALNECKER SUSAN M
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-04 | 4 | Bioventus Inc. (BVS) | Option exercise (M): 32,282 @ $0 · Option exercise (M): 32,282 (derivative) @ $0 · Grant/award (A): 25,146 (derivative) @ $0 | EDGAR |
| 2025-06-04 | 4 | Bioventus Inc. (BVS) | Option exercise (M): 26,493 @ $0 · Option exercise (M): 26,493 (derivative) @ $0 · Grant/award (A): 32,282 (derivative) @ $0 | EDGAR |
| 2025-02-19 | 4 | Leidos Holdings, Inc. (LDOS) | Option exercise (M): 4,070 @ $63.08 · Option exercise (M): 3,345 @ $75.02 · Option exercise (M): 2,123 @ $103.90 · Option exercise (M): 1,769 @ $104.06 · Option exercise (M): 2,296 @ $79.45 · Tax withholding (F): 8,278 @ $132.26 · +5 more | EDGAR |
| 2024-06-13 | 4 | Bioventus Inc. (BVS) | Grant/award (A): 26,493 (derivative) @ $0 | EDGAR |
| 2024-06-11 | 4 | Bioventus Inc. (BVS) | Option exercise (M): 30,400 @ $0 · Option exercise (M): 30,400 (derivative) @ $0 | EDGAR |
| 2024-05-07 | 4 | Leidos Holdings, Inc. (LDOS) | Grant/award (A): 912 @ $0 · Grant/award (A): 1,179 (derivative) @ $0 | EDGAR |
| 2024-05-03 | 4 | Leidos Holdings, Inc. (LDOS) | Option exercise (M): 4,788 @ $52.70 · Tax withholding (F): 1,774 @ $142.19 · Sale (S): 3,014 @ $141.97 · Option exercise (M): 4,788 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1221375 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →